-
Investigating Functional Status and Healthcare Resource Utilization of Patients With Cognitive Impairment Associated With Schizophrenia: Findings From a Real-World Noninterventional Study
Sep 9, 2025, 16:22 PM -
Prevalence of Post-Traumatic Stress Disorder Among Ambulance Officers During the COVID-19 Pandemic
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use Among Children With Mucopolysaccharidosis Type III MPS III: A Retrospective Claims Database Analysis in the US
Sep 9, 2025, 16:22 PM -
(HCRU)/Costs and Epidemiology of Patients With ADHD in Germany: A Claims Data Study (HEDDA)
Sep 9, 2025, 16:22 PM -
Orphan Drugs Availability in Israel: A Base for Policy Development
Sep 9, 2025, 16:22 PM -
HTA Requirements for Medical Technologies in Germany
Sep 9, 2025, 16:22 PM -
Deep Real-World Analysis of Patients With Myelofibrosis Using Natural Language Processing and Machine Learning: A Methods Description
Sep 9, 2025, 16:22 PM -
MCDA Tool Adoption in Egypt: Room for Sustainability and Accessibility
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Societal Perspectives in the EU Joint Clinical Assessment Framework and in EU-27 Health Technology Assessment Guidelines
Sep 9, 2025, 16:22 PM -
Impacts of Patient-Centered Collaboration: Application of a Continuous Engagement Plan Across Multiple Phases of the Insights and Patient Experiences With Cardiovascular Disease (IPEC) Initiative
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Reimbursement Landscapes: Advantages and Challenges of Bispecifics vs. CAR-T Therapies
Sep 9, 2025, 16:22 PM -
The Economic Value of Self-Administered Subcutaneous Immunoglobulin G (SCIg) in Canada: A Scoping Review
Sep 9, 2025, 16:22 PM -
Diverging Impacts of Evergreening and Biosimilars on Trastuzumab Utilization and Costs in South Korea: Implications for Sustainable Access and Market Competition
Sep 9, 2025, 16:22 PM -
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
Avacopan in the Treatment of ANCA-Associated Vasculitis: A Cost-Utility Analysis in Portugal
Sep 9, 2025, 16:22 PM -
The Costs of Loneliness-Related Health Consequences in Finland
Sep 9, 2025, 16:22 PM -
Utility of Minimum Dataset for Generation of Real-World Data in a Context With Evidence Gaps: The Left Ventricular Assist Devices as Destination Therapy
Sep 9, 2025, 16:22 PM -
Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Delaying Type 1 Diabetes Progression: A New Cost-Effectiveness Model for Capturing the Value of Delayed Onset
Sep 9, 2025, 16:22 PM -
Effectiveness of Community Health Worker vs. Professional Care in Obesity Management: Preliminary Findings From a SMART Trial
Sep 9, 2025, 16:22 PM
